Myocardial and skeletal muscle responses to hemorrhage and shock during  -adrenergic blockade.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000502:physiology; D001794:Blood Pressure; D002302:Cardiac Output; D002404:Catheterization; D003326:Coronary Circulation; D004285:Dogs; D005260:Female; D005947:Glucose / Q000378:metabolism; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006339:Heart Rate; D006885:Hydroxybutyrates / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D010710:Phosphates / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D012039:Regional Blood Flow; D012771:Shock, Hemorrhagic / Q000503:physiopathology*
D000317:Adrenergic alpha-Antagonists; D006885:Hydroxybutyrates; D007773:Lactates; D010710:Phosphates; D011773:Pyruvates; D005947:Glucose